arrow
P

Peter E. Penson

Medical University of Silesia
H指数:42
被引数:5,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studies

肥胖的患病率及其与LIPIDOGRAM研究中心血管代谢危险因素的关系

2026-01-010
PRE
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)

国际脂质专家小组(ILEP)关于一级和二级卒中预防的脂质管理共识论文

2025-11-160
PRE
Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis

Penson PE,Toth PP;代表血脂与血压荟萃分析合作组(LBPMC)和国际血脂专家委员会(ILEP)他汀联合依折麦布的降脂疗法与单用他汀治疗对心血管结局降低的影响:一项荟萃分析

2025-03-230
PRE
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
DRUGS
IF14.4
2024-11-041
OAAI
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS): study design and methodology

使用多基因风险评分 (PRS) 对LIPIDOGEN2015人群进行8年随访,基于常见遗传变异的不良心血管事件风险: 研究设计和方法

2024-08-081
OAAI
Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18

坚持房颤改善护理路径和房颤老年疗养院居民不良健康结局的风险: 一项回顾性数据关联研究2003-18

2024-02-221
OAAI